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We use a small animal model, based on guinea pigs infected with a non-pathogenic Pichinde virus
(PICV), to understand the virulence mechanisms of arenavirus infections in the hosts. PICV P2 strain
causes a mild febrile reaction in guinea pigs, while P18 causes severe disease with clinical and
pathological features reminiscent of Lassa hemorrhagic fever in humans. The envelope glycoproteins
(GPC) of P2 and P18 viruses differ at positions 119, 140, and 164, all localized to the receptor-binding
G1 subunit. We found that lentiviral pseudotyped virions (VLPs) bearing P18 GPC show more efﬁcient
cell entry than those with P2 GPC, and that the E140 residue plays a critical role in this process.
Infection of guinea pigs with the recombinant viruses containing the E140K change demonstrated that
E140 of GPC is a necessary virulence determinant of P18 infections, possibly by enhancing the ability of
virus to enter target cells.
& 2012 Elsevier Inc. All rights reserved.Introduction
Lassa virus (LASV), an Old World (OW) arenavirus, causes
endemic Lassa fever in West Africa with estimated 300,000–
500,000 infections and 5000 deaths annually (Khan et al., 2008;
McCormick and Fisher-Hoch, 2002). In South America, several
New World (NW) arenaviruses, such as Junin (JUNV) and
Machupo (MACV), cause sporadic hemorrhagic fever diseases
(Buchmeier et al., 2007). Novel arenaviruses that can cause
hemorrhagic fever diseases have also been identiﬁed in recent
years (Briese et al., 2009; Delgado et al., 2008), highlighting the
urgency to develop much-needed preventive and therapeutic
measures. Efforts to develop antiviral approaches, however, have
been hampered by the lack of in-depth understanding of the
mechanisms of arenavirus replication and pathogenesis due to
the strict requirement of Biosafety-Level 4 (BSL-4) containment to
work with these live pathogenic arenaviruses.ll rights reserved.
d Biomedical Sciences,
295 AS/VM Building., Saint
tral Institute of Research on
hdoom, P.O. Farah 281122,
y and Immunology, Emory
Laboratory Medicine, EmoryPichinde virus (PICV) is a NW arenavirus that is non-pathogenic
in humans and can be safely studied at BSL-2. Its natural host is the
Columbian rice rat Oryzomys albigularis (Trapido and Sanmartin,
1971). Whereas a low number of passages of PICV in inbred guinea
pigs produce an avirulent virus that causes a brief febrile reaction,
extended passage in inbred guinea pigs has led to the isolation of
highly pathogenic strains that cause severe disease characterized by
fever, severe weight loss, terminal shock syndrome, and death,
similar to those found in human Lassa fever (Aronson et al., 1994;
Jahrling et al., 1981; Lucia et al., 1990; McCormick et al., 1987; Qian
et al., 1994). Due to the difﬁculty in maintaining inbred strain 13
guinea pigs, Aronson and her colleagues have shown that similar
distinct disease patterns were also observed in outbred Hartley
guinea pigs infected by a low passge (e.g., strain P2) and a high
passage (e.g., strain P18) PICV strains (Zhang et al., 2001). PICV
infection in guinea pigs, therefore, represents a safe, convenient, and
economical small animal model to investigate the pathogenesis of
arenavirus hemorrhagic fevers (Aronson et al., 1994; Cosgriff et al.,
1987; Jahrling et al., 1981; Schaeffer et al., 1993). Understanding the
virulence mechanisms by which the two closely related PICV strains
cause distinct disease outcomes in guinea pigs is expected to shed
important lights into those of pathogenic arenaviruses in humans.
We have identiﬁed several amino acid differences in the viral coding
sequences, including three mutations in the viral envelop glycopro-
tein (GPC) (Lan et al., 2008). We propose that these GPC mutations
may be important virulence determinants.
Arenavirus envelope glycoprotein is translated as a precursor
protein that is cleaved by signal peptidase and the SKI-1/S1P
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Fig. 1. Characterization of the GPC-mediated cell entry by GPC-pseudotyped
lentiviral VLPs. (A) Expressions of P2, P18, and P18 mutant GPC proteins in the
transfected 293T cells. Western blot analysis was conducted using guinea pig anti-
PICV serum. (B) Detection of G1/G2 and HIV-1 p24 in the puriﬁed VLPs by western
blot analysis. Intensity of each band was quantiﬁed by the Image J analysis
software and normalized to that of P18.
N. Kumar et al. / Virology 433 (2012) 97–10398protease into three subunits: 58-aa stable signal peptide (SSP) as
well as the canonical receptor-binding and transmembrane fusion
subunits (G1 and G2, respectively) (Buchmeier et al., 2007).
Arenavirus SSP is unique in that it is a component of the mature
GPC complex and plays important roles not only in regulating the
intracellular trafﬁcking and proteolytic maturation of the GPC
complex, but also in pH-induced membrane fusion activity and
virus entry (Agnihothram et al., 2006; York and Nunberg, 2006,
2009). G1 is variable among arenaviruses and determines recep-
tor speciﬁcity. So far two arenavirus receptors have been identi-
ﬁed, the alpha-dystroglycan used by OW and NW Clade C
arenaviruses such as LASV and LCMV (Cao et al., 1998;
Spiropoulou et al., 2002), and transferrin receptor 1 used by NW
Clade B arenaviruses such as JUNV and MACV(Abraham et al.,
2009; Radoshitzky et al., 2007). The receptor for NW Clade A
arenaviruses such as PICV is unknown. The G2 subunit contains a
fusion peptide and a transmembrane (TM) domain, and is
involved in fusion activity (Buchmeier et al., 2007).
Avirulent P2 GPC differs from virulent P18 by three residues at
positions 119, 140, and 164, all localized to the receptor-binding
G1 subunit (Lan et al., 2008). In this study, we characterized the
effects of these GPC mutations on viral entry using a pseudotyped
lentivirus system, and on viral virulence in guinea pigs using
recombinant PICV mutants (Lan et al., 2009). Our studies reveal
that a single amino acid E140 in GPC increases the GPC-depen-
dent virus entry in vitro and is also a necessary virulence
determinant of P18 infections in vivo.Table 1
Efﬁciency of various GPC-incorporated VLPs in
transducing guinea pig ﬁbroblast JH4 cells.
GPC constructs (GFP-positive) %n
P18 40.0372.14
P2 0.0570.005
P18-T119S 34.1370.78
P18-E140K 8.9470.64
P18-V164I 41.470.17
P18-T119S/E140K 10.2270.23
P18-T119S/V164I 25.5770.45
P18-E140K/V164I 9.6570.69
P18-T119S/E140K/V164I 0.0770.009
n Results shown are the averages of at least
three independent experiments with standard
deviation.Results
P18 GPC protein mediates more efﬁcient cell entry than P2 GPC
protein in a pseudotyped virus system
Studies from our laboratory as well as others have shown that
P18 PICV causes severe hemorrhagic fever-like disease in guinea
pigs, in contrast to the avirulent P2 strain (Lan et al., 2009; Zhang
et al., 1999; Zhang et al., 2001). The molecular mechanisms
underlying these differences in pathogenesis are unknown. We
have shown that the P2 and P18 genomes differ by several
encoded amino acids, including three missense mutations located
within the receptor-binding G1 subunit of the GPC protein
(Lan et al., 2008), which we hypothesize to affect the efﬁciency
of GPC-mediated cell entry. To compare entry efﬁciency mediated
by P2 and P18 GPC, we generated lentivirus-like particles contain-
ing P2 or P18 GPC proteins using an established three-plasmid
system (Naldini et al., 1996). Brieﬂy, 293T cells were transfected
with: pCMV-DR8.2, a plasmid containing the HIV genome except
for the packaging signal and envelope gene; pHR0, a plasmid
containing a GFP expression cassette and HIV packaging signal;
and a pCAGGS expression vector expressing either P2 or P18
GPC proteins. Pseudotyped viral-like particles (VLPs) incorporat-
ing the respective GPC protein were harvested from the cell-
culture supernatants. P2 and P18 GPC proteins were expressed at
similar levels in transfected 293T cells (Fig. 1A) and showed
similar cleavage of precursor GPC into mature G1 and G2 (Fig. 1A).
Puriﬁed GPC-pseudotyped VLPs contained similar ratios of G1/G2
to HIV-1 capsid (p24) protein (Fig. 1B), demonstrating that P2 or
P18 GPCs were incorporated into VLPs with similar efﬁciencies.
Upon transduction of guinea pig ﬁbroblast JH4 cells with similar
amounts of the VLPs, GFP expression was efﬁciently and consis-
tently detected in cells transduced using P18 VLPs. In contrast,
GFP expression was rare in cells transduced using P2 VLPs. Flow
cytometric analysis determined transductions efﬁciencies of 40%
and 0.05%, respectively, in P18 and P2 VLP-transduced cultures
(Table 1). Similar results were obtained in multiple cell lines,including 293T, human endothelial cells SLK, human foreskin
ﬁbroblast (HFF) cells, Chinese hamster ovarian (CHO) cells,
human lung epithelial cells A549, and mouse ﬁbroblast cells
3T3 (data not shown), indicating that P18 GPC is signiﬁcantly
more efﬁcient for cell entry independent of host cell species or
cell type.
Amino acid E140 is critical in enhancing pseudotyped virus-mediated
cell entry
To identify the P18-speciﬁc residue(s) responsible for
increased cell entry, we compared the entry efﬁciency of VLPs
bearing one or more P2 mutations in JH4 cells (Table 1). A single
P2-speciﬁc mutation at residue 140 (E140K), but not at 119
(T119S) or 164 (V164I), caused a signiﬁcant reduction in VLP
entry efﬁciency from 40% to 9%, suggestive of a critical role of
E140 in enhancing GPC-mediated cell entry. It is noteworthy that
the E140K VLPs were still more efﬁcient than P2 GPC-containing
VLPs in transducing cells (9% vs. 0.05%), implying that the other
two amino acid substitutions may also participate at some levels
to optimize cell entry. Indeed, the T119S/V164I double mutant
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Fig. 3. Virulence determination of recombinant PICV strains in guinea pigs. Each
group (n¼9) of male outbred Hartley guinea pigs were infected intraperitoneally
with 10,000 PFU of recombinant viruses rP18, rP2, rP18-triple-mut, or rP18-E140K
for up to 18 days. (A) The average of daily rectal temperature is shown. (B) The
average of daily body weight is shown. (C) The survival curve of animals infected
with recombinant viruses. Statistical signiﬁcance was as determined by Log-rank
(Mantel-Cox) w2 Test.
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transduction efﬁciency, whereas the triple mutant (T119S/E140K/
V164I) reduced cell entry to a similar level (0.07%) as that of the
P2-GPC containing VLPs. Collectively, our data suggest that the
E140 residue is critical in enhancing GPC-mediated cell entry, and
this effect is potentiated by T119 and/or V164 residue.
Generation of recombinant P18 viruses with P2-speciﬁc
residues in GPC
Taking advantage of our PICV reverse genetics system (Lan
et al., 2009), we generated recombinant PICV viruses carrying a
single E140K or triple T119S/E140K/V164I mutation in the P18
virus backbone (rP18-E140K and rP18-triple-mut, respectively).
The recombinant viruses were plaque-puriﬁed and mutations
were conﬁrmed by sequence analysis. Viral growth was compared
in BHK-21 cells with both high and low moi (Fig. 2). Differences
seen in virus entry using pseudotyped VLPs were reduced in the
context of recombinant virus. Nonetheless, rP18 replicated to
slightly higher titer than rP2 (0.5 log), as we have previously
reported (Lan et al., 2009; Liang et al., 2009), while the mutants
grew intermediately at high moi and aligned more with rP2 than
with rP18 at low moi (Fig. 2). Similar growth kinetics were also
observed in U937 cells (data not shown).
E140 is a virulence determinant of PICV infection in vivo
We compared the degrees of virulence of the recombinant
PICV strains in guinea pigs by following the established protocol
(Lan et al., 2009). Brieﬂy, male Hartley guinea pigs (n¼9) were
infected i.p. with 104 pfu of rP2, rP18, rP18-E140K, and rP18-
triple-mut, respectively, and monitored daily of body weight and
rectal temperature for up to 18 days post-infection (dpi). Animals
were euthanized when they have reached predetermined term-
inal points as approved by our institutional IACUC committee.
As previously reported, all animals that have been infected with
the avirulent rP2 experienced a brief period of fever (average of
1–2 days) but maintained their body weights (Fig. 3A and B). In
contrast, all 9 animals that have been infected with virulent rP18
suffered from a long duration of fever (average of 8–9 days) and
signiﬁcant body weight loss, and had to be euthanized (100%
mortality due to reaching terminal points) (Fig. 3A and B).
Animals infected with either of the two GPC mutant viruses,
however, showed variable outcomes: some showing similar con-
sequences as rP18-infected ones and euthanized when reaching
terminal points, others recovered from the infections as evi-
denced by increased body weight and fever reduction (Fig. 3ArP2
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N. Kumar et al. / Virology 433 (2012) 97–103100and B). As shown in the survival curve (Fig. 3C), virulent rP18
caused 100% mortality within 15 dpi, in contrast to 0% for
avirulent rP2. The rP18-triple-mut and rP18-E140K viruses each
showed 33–40% survival rate that is signiﬁcantly different from
the rP18 control (Fig. 3C) suggesting that both GPC mutant
viruses are less virulent than rP18. There is, however, no sig-
niﬁcant difference in the survival curves between animals
infected with the single and triple mutant viruses.
As arenavirus virulence correlates with the level of viral
replication in vivo, we quantiﬁed titers of the viruses in blood
and in different organs of infected animals. Viremia level was
compared at 9 dpi and at 18 dpi or terminal points (Fig. 4A).
At both time points, the rP2-infected animals had below-the-
threshold viremia level, whereas the rP18-infected animals all
contained high (105 pfu/ml) viral titers in blood. Animals
infected with the GPC mutant viruses (rP18-E140K and rP18-
triple-mut) had 2 log lower viremia (103 pfu/ml) at 9 dpi than*******
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Fig. 4. Comparison of recombinant PICV strains in viral replication in vivo.
(A) Viremia levels of infected animals at day 9 and day 15 post-infection. (B)
Viral titers in internal organs (liver, lung, spleen and lymph nodes) at terminal
points or at the end of infection (18 dpi). Statistical analysis was conducted using
the Student’s t-test. po0.05 and po0.01 indicated by **, po0.001 by ***, and
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Fig. 5. Histopathological analysis of liver specimens from guinea pigs infected with rec
hepatocytes and arrowhead shows inﬁltrated lymphocytes.those with rP18. These GPC mutants-infected animals had very
low (o100 pfu/ml) to undetectable viral titers in blood at 18 dpi
if they have survived the infections, and had 2 log in average
lower viremia than rP18-infected ones at terminal points (TP)
(Fig. 4A). Consistent to viremia level, the rP2-infected animals
completely cleared virus infections from tested organs such as
liver, lung, spleen, and lymph nodes at the end of the experiment
(18 dpi), whereas the rP18-infected animals contained high titers
of viruses, ranging from 106 pfu/g in lymph nodes to 108 pfu/g in
livers, at terminal points (Fig. 4B). The GPC mutants-infected
animals had very low (o1000 pfu/g) to undetectable viral titers
in the tested organs at 18 dpi if they have survived from the
infections, and had signiﬁcantly lowered viral titers in organs
than rP18-infected ones even when they have succumbed to the
infections (Fig. 4B). On average, the differences in viral titers in
various organs between the GPC mutant viruses and rP18 are
1 log in spleens,2 logs in lymph nodes, 3 logs in lungs, and
3–4 logs in livers (Fig. 4B). Taken together, our results clearly
show that the GPC mutants replicate at much lower level than
rP18 does in vivo.
Comparison of liver histopathology also showed differential
degrees of virulence in animals infected by different virus strains.
The rP2-infected animals did not show any obvious liver pathol-
ogy, the rP18-infected ones showed most severe lesions, whereas
the GPC mutants caused intermediate levels of pathology (Fig. 5).
For rP18-infected animals, the normal architecture of the hepatic
cords is distorted due to marked hepatocellular vacuolar degen-
eration, and necrotic hepatocytes are scattered with possible
lymphocyte inﬁltration (Fig. 5). Guinea pigs that recovered from
either GPC mutant infection did not show any obvious liver
pathology (data not shown), similar to the rP2-infected animals.
The moribund animals infected with either GPC mutant virus
exhibited a generally less liver pathology than the rP18-infected
ones as evidenced by less hepatocellular vacuolar degeneration
and less hepatocellular necrosis (Fig. 5), which correlates with the
average 3–4 logs lower levels of mutant viruses than rP18 in the
livers (Fig. 4B). Therefore, the GPC mutant viruses also caused less
pathogenesis in animals than the virulent rP18 virus.
Collectively, these in vivo data demonstrate that the introduc-
tion of P2-speciﬁc residue(s) to P18 GPC signiﬁcantly reduced the
P18 virulence in vivo, as demonstrated by the increased survival
rate (Fig. 3), the decreased viral titers (Fig. 4), and the reduced
liver pathogenesis (Fig. 5). No obvious difference in the degree of
virulence (survival curve, viral titer, and liver pathology) was
detected between the single (E140K) and the triple GPC mutants.
Therefore, we conclude that the single E140 residue of GPC is an
important virulence determinant of P18 infections in vivo.Discussion
Among Arenaviridae family members, only a few can cause
virulent infections in unnatural hosts, such as arenavirus-induced
hemorrhagic fevers in humans, the reasons of which are largely
unknown. A postulated hypothesis proposes that the viralombinant PICV strains after hematoxylin and eosin staining. Arrow shows necrotic
N. Kumar et al. / Virology 433 (2012) 97–103 101genome may encode critical determinants for virulence. We use a
safe small animal model, in which two PICV strains derived from
low (P2) and high (P18) passages in guinea pigs can respectively
cause avirulent and virulent infections with opposing outcomes in
the animals, to characterize the virulence-associated determi-
nants in arenavirus genome. Compared to the variable mortality
rates of outbred guinea pigs infected with virulent PICV in
previous studies (Jahrling et al., 1981; Scott and Aronson, 2008),
we have observed more consistent high mortality rate and
hemorrhagic fever symptoms in our infected animals (Figs. 3–5),
which is likely due to different experimental settings between our
study and others. Knowledge of virulence mechanisms learned
from the PICV-guinea pig model can be extrapolated to other
pathogenic arenaviruses in humans. Through site-directed muta-
genesis and comprehensive characterization of the mutant
viruses in this study, we have shown that the E140 residue within
the receptor-binding GP1 subunit is an essential virulence deter-
minant of P18 infection of guinea pigs, as the E140K substitution
can signiﬁcantly reduce viral replication and pathogenesis in vivo
(Figs. 3–5). We have also provided evidence to suggest that the
molecular mechanism by which the E140 residue enhances viral
replication and virulence is possibly due to its ability to enhance
cell entry efﬁciency as demonstrated in the pseudotyped lenti-
viral system (Table 1).
Using pseudotyped VLPs, we have shown that GPC of virulent
P18 virus can mediate a much more efﬁcient cell entry than that
of avirulent P2 into a variety of cell lines (data not shown).
The correlation of cell entry efﬁciency and viral virulence in vivo
has led us to believe that GPC-mediated cell entry may be an
important virulence mechanism of arenavirus infection in vivo. As
P2 and P18 GPC proteins differ at three amino acids, 119, 140, and
164, within the G1 subunit that mediates speciﬁc binding to host
receptor(s) (Lan et al., 2008), we hypothesize that these residues
can affect virus–cell binding to inﬂuence the virus entry efﬁ-
ciency. By systematic mutagenesis, we learn that the K140E
substitution with a change from positive to negative side chain
of the amino acid during the P2-P18 adaptation is essential in
enhancing cell entry, which can be further augmented by the
S119T or I164V substitution (Table 1). However, the exact
molecular mechanism by which these amino acid substitutions
enhance GPC-mediated cell entry requires a better understanding
of PICV GPC interaction with its host receptor(s) at the atomic
level, information of which is not available at the moment. The
entry receptor of PICV as well as other members of Clade A NW
arenaviruses has not yet been identiﬁed, although we have
produced preliminary data to suggest that PICV does not primar-
ily use a-DG or TfR1 for entry (unpublished data).
Additionally, we have provided evidence to demonstrate the
important role of the E140 residue in mediating PICV replication
and virulence in vivo. We have shown that a single amino acid
substitution of E140 with the P2-speciﬁc residue K in the genome
of virulent rP18 virus has improved survival rate of infected
animals (Fig. 3). Furthermore, this E140K single substitution has
led to signiﬁcantly lower level of viral replication in vivo by at
least 2 logs in blood and by 1–4 logs in various organs (Fig. 4), and
subsequently less liver pathogenesis (Fig. 5), even in the mor-
ibund animals. Our in vivo data have provided evidence for E140
as one of the important virulence determinants of P18 infection in
guinea pigs, which correlates well with its role in increasing GPC-
dependent virus entry in vitro. It is noteworthy that compared to
the pronounced 1–4 log difference in viral replication in vivo
(Fig. 4), the GPC mutant viruses replicate only slightly less than
the parental rP18 virus by o0.5 log in vitro (Fig. 2A). This could
be explained by the differences between the in vivo and in vitro
experimental conditions, among which host immunity may play
an important role in amplifying the differential infectivity of viralstrains in vivo. As early target cells of arenavirus infections are
macrophages and DCs, which are immune cells important for
both innate and adaptive immune responses, differential entry
efﬁciency into these early target cells due to GPC mutations not
only can lead to intrinsically different viral replication levels but
may also affect host immunity that in return leads to even greater
differences in viral growth in vivo. Regardless of the mechanisms,
our data show that the GPC-mediated differential cell entry into
host target cells leads to the differences in viral growth in vivo.
This GPC-dependent virulence mechanism is also supported by
a recent report demonstrating that a single mutation in LCMV
GPC is necessary and sufﬁcient for receptor binding, dendritic cell
infection, and long-term persistence (Sullivan et al., 2011). It is
important to note, however, that mutations in GPC alone did not
reduce PICV viral virulence to the level of rP2 (Figs. 3–5)
suggesting the contribution of other possible viral virulence
factors besides GPC. We have recently produced evidence to
demonstrate that both viral L polymerase and nucleoprotein
(NP) may also play important roles in mediating virus virulence
((Liang et al., 2009) and our unpublished data). Efforts to char-
acterize the virulence-associated mutations in the NP and L
proteins are currently underway. Taken together, our study
suggests that virulent arenavirus infections are a complex process
that requires the synergetic functions of different viral proteins,
including but not necessarily limited to GPC, to increase viral
entry and RNA synthesis, and to effectively evade host immune
detection (Fan et al., 2010; Martinez-Sobrido et al., 2006; Qi et al.,
2010).Materials and methods
Cells
293T (human kidney epithelial), SLK (human endothelial),
human foreskin ﬁbroblast (HFF), A549 (human embryonic lung
epithelial) and NIH 3T3 (mouse embryonic ﬁbroblast) were grown
in DMEM supplanted with 10% fetal bovine serum (FBS). JH4
(guinea pig lung ﬁbroblast) and Chinese hamster ovary epithelial
(CHO) were grown in DMEM F12 supplemented with 10% FBS.
Vero cells were grown in MEM supplemented with 10% FBS.
Human monocytic U937 cells were grown in RPMI-1640 supple-
mented with 10% FBS.
GPC protein vector construction, mutagenesis, and expression
We ampliﬁed the GPC genes from P2, and P18 virion RNAs and
subcloned each into pCAGGS expression vectors. The resulted
plasmids are named pCAGGS-P2-GPC, and pCAGGS-P18-GPC.
Single, double, and triple mutations were introduced into the
P18 GPC protein at three residues (T119S, E140K, and V164I) by
PCR-mediated site-directed mutagenesis and conﬁrmed by
sequencing. Expression of various GPC proteins was examined
by transfection of 293T cells with the individual expression
vectors, followed by Western blot analysis using anti-PICV guinea
pig sera.
Generation of pseudotyped lentivirus-like particles (VLPs)
293T cells were transfected with pHR’GFP, pCMVRD8.91, and
the individual GPC expression vectors using Lipofectamine 2000
(Invitrogen). Supernatants of the transfected cells were collected
at different time points up to 96 h post-transfection and ﬁltered
through a 0.45 mm ﬁlter. After puriﬁcation through sucrose
gradient ultracentrifugation, the pseudotyped VLPs were resus-
pended in DMEM, aliquoted, and stored at 80 1C. The amount of
N. Kumar et al. / Virology 433 (2012) 97–103102VLPs was normalized by the HIV-1 p24 levels as determined by
Western blot analysis using an anti-HIV-1 p24 antibody, which is
kindly provided by Dr. E. Hunter (Emory University).
Quantiﬁcation of GPC-mediated cell entry efﬁciency of VLPs
Target cells were infected with pseudotyped VLPs at moi of
1 in the presence of 2 mg/ml polybrene for 2 h, and replaced with
fresh media. GFP protein expression was detected at 72 h post-
infection (hpi), either under a ﬂuorescent microscope or by ﬂow
cytometric analysis. The efﬁciency of cell entry was measured by
the percentage of cells expressing the GFP protein (GFPþ%).
Generation of recombinant viruses
Respective GPC mutations (single E140K and triple T119S/
E140K/V164I mutations) were introduced to the plasmid encod-
ing the full-length anti-sense S segment of P18 virus by
PCR-mediated mutagenesis and conﬁrmed by sequencing. Recom-
binant PICV viruses were generated as described before (Lan et al.,
2009). Brieﬂy, plasmid encoding either WT or mutant P18 S
segment, together with plasmid encoding P18 L segment, was
transfected into BSRT7-5 cells that stably express T7 polymerase.
Recombinant viruses were plaque puriﬁed from the supernatants
of the transfected cells, sequence veriﬁed by RT-PCR, and ampli-
ﬁed in BHK-21 cells. Viral titer was determined by plaque assay.
Determination of viral growth kinetics in vitro
BHK-21 cells were infected with WT or mutant recombinant
PICV viruses at moi of 5 or 0.01 for 1 h. After PBS wash for three
times, cells were replaced with fresh media. At various times
post-infection, viral titers in the supernatants were determined
by plaque assay. Viral production at various time points was
similarly quantiﬁed by plaque assay as described above.
Guinea pig experiments
The experimental procedures for guinea pigs followed the
approved protocol of the Institutional Animal Care and Use
Committee (IACUC) of the Emory University. Brieﬂy, healthy
400 g–500 g male outbreed Hartley guinea pigs were housed to
acclimatize for 5–7 days after which each group (n¼9) of animals
were injected intraperitoneally with 10,000 PFU of rP18, rP2,
rP18-triple-mut (T119S/E140K/V164I) and rP18-E140K, respec-
tively. Rectal temperature and body weight were measured daily
for up to 18 days. Blood was drawn from the marginal ear vein at
different days post-infection (dpi). Guinea pigs were declared
moribund and euthanized if body weight decreased by 30% when
compared to the control group or if animals reached other set
terminal points as approved by Emory University IACUC. Virus
titration in serum and in tissue specimens was determined by
plaque assay in vero cells as described before (Lan et al., 2009).
Histopathological analysis was conducted after hematoxylin and
eosin staining of formalin-ﬁxed tissue section. Statistical analyses
of the survival curve by Log-rank (Mantel-Cox) w2 Test were
conducted using GraphPad prism 5 software. Statistical signiﬁ-
cance of viral titers in serum and in different tissue sample was
analyzed by ‘‘t’’ test.Acknowledgments
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